MiNK Therapeutics Inc (NASDAQ:INKT) concluded the trading at $23.25 on Thursday, June 04 with a rise of 0.61% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $23.11 and 5Y monthly beta was reading 0.148 with its price kept floating in the range of $23.2001 and $30.3 on the day. Considering stock’s 52-week price range provides that INKT hit a high price of $76.00 and saw its price falling to a low level of $4.56 during that period. Over a period of past 1-month, stock came adding 207.02% in its value.
With its current market valuation of $92.67 million, MiNK Therapeutics Inc is set to declare its quarterly results on 2025-May-15. Analysts are in estimates of -0.46 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -1.98 for current year with estimates of that growing to -1.85 in next year.
Digging deeper we become aware of the PEG ratio of the INKT stock which is currently positioned at 0. It further provides that stock’s current price level is 60.84% away from its 20-day simple moving average and is 128.86% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 55.18 while volatility remained at 84.19% over the past week which changes to 24.09% when measuring it over the past month. Beta is valued at 0.22. In predicting price targets of as low as $35 and as high as $35, analysts are in agreement on assigning the stock over the next 12 months average price target of $35. Stock’s current price level is -50.54% above from estimated low price target while it is -50.54% below the estimated high; and even if the INKT’s share succeeded to reach the median price of $35, then the outlook of -50.54% could come to the excitement of the investors.
Having a second look at MiNK Therapeutics Inc (NASDAQ:INKT) provides that stock’s average daily trading volume for 3 months was 913.42K, while it jumped to 5291620 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 3.97 million.
The percentage of outstanding shares held by the insiders is 75.14% while it is 1.58% for the institutional holders. The figures also indicate that as of 2025-06-13, number of stock’s short shares was 10657.0 which implies a short ratio of 2.44. This shows down a 103.00 of Short Interest in company’s outstanding shares on the day. In June the standing of shares short improved as it was 21964.0 in the previous month. Addition of 103.95% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
